Simbiosys
Chicago, US · Founded 2018 · Delaware corporation · 4 known investors
Find your way into Simbiosys
265 people in our graph share verified history with the Simbiosys team — schools, employers, funds. One of them is your warm intro.
Rony Patishi-Chillimunlockedknows Stacey Stevens · together at Questrom School of Business, Boston University (overlapped)
×5knows the team · via University of New Hampshire
×5knows the team · via Questrom School of Business, Boston University
knows the team · via Simbiosys
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
Founders & leadership
Simbiosys was founded in 2018 by Joe Peterson, John Cole, and Tushar Pandey.
JP
Joe PetersonCo-founder
JC
John ColeCo-founder
TP
Tushar PandeyinCo-founder
SS
Stacey StevensinPresident and CEOStacey Stevens is an executive officer and director at SimBioSys with over twenty years of experience in medical technology, including background in commercial leadership, clinical imaging applications in oncology and radiology, capital raising, and strategic partnerships.
Board
VC
LC
Lucy CoassinBoard director
RA
Ronnie AndrewsBoard director
WH
Investors · 4
Reported raises · per SEC filings
Form D private placements$6.1M disclosed across 2 rounds · 2018–2024
▶$5.2MraisedJan 2025 · 13 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lucy CoassinDirector
- Vikram ChaudheryDirector
- Ronnie AndrewsDirector
- William HyunDirector
- Joseph PetersonExecutive Officer, Director
- Stacey StevensExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · 3 investors · BiotechnologyRule 506(b)
▶$900KraisedNov 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John A ColeExecutive Officer
- Joseph R PetersonExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $900K
- Minimum investment
- $50K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Simbiosys do?
- SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
- Who founded Simbiosys?
- Simbiosys was founded by Joe Peterson, John Cole, Tushar Pandey in 2018.
- Who are Simbiosys's investors?
- Simbiosys's investors include AV8 Ventures, Genoa Ventures, GENERAL INCEPTION, Northpond Ventures.
- How much funding has Simbiosys raised?
- Simbiosys has disclosed $6.1M raised across 2 rounds.
- Where is Simbiosys headquartered?
- Simbiosys is headquartered in Chicago, US.